Sponsored Links 
Company News for June 29, 2009
• FBR Capital downgraded Alcoa (NYSE:AA - Snapshot Report) to "underperform" from "market perform," citing valuation and oversupply concerns
• According to an unidentified report of a clinical study out of Europe, insulin users of long-acting drugs showed increased cancer risks. Manufactures of such drugs include Sanofi Aventis (NYSE:SNY - Analyst Report) and Novo Nordisk (NYSE:NVO - Snapshot Report), while Amylin (NASDAQ:AMLN - Analyst Report) manufactures a non-insulin-based treatment
• According to news reports, Novartis (NYSE:NVS - Snapshot Report) is in talks to acquire parts of Elan (NYSE:ELN - Snapshot Report), including its multiple sclerosis drug Tysabri and its pipeline of Alzheimer's drugs
 |
 |
 Share |
 RSS |
 Rate Pos |
 Rate Neg |
 Comment |
|
|
||||||
Loading Stories...Related Content
Loading Stories...Most Popular on Zacks.com
0.00 %
-0.94 %
0.33 %
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
More Zacks Links
| Market Summary | Nov 08, 2009 03:58 am ET |
Sponsored Links
[CLICK TO CLOSE X]